Solvemed Groupsp. z o.o.
Research and experimental development in natural sciences and engineering
Overview
Solvemed Group is a company that offers the PuRe™ Pupillometer, a device designed for objective pupil reactivity testing that is free from ambient light influence. The pupillometer features superior accuracy, requires no disposables, and allows for instant electronic medical record (EMR) uploads.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2021-04-01. Active
02 1050 1025 1000 0090 8379 3100
21 1140 1010 0000 3506 9100 1001- 37 1140 1010 0000 3506 9100 1004
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Apr 4, 2022 | Aid for SME access to finance — risk finance aid | $1.5M$1,501,404 | PFR Ventures sp. z o.o. | |
| Apr 4, 2022 | Aid for SME access to finance — risk finance aid | $448.6K$448,627 | PFR Ventures sp. z o.o. | |
| Dec 3, 2020 | Aid in the form of risk capital | $511.0K$511,029 | PFR Ventures sp. z o.o. |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
If the company has a one-person management board, the sole member of the management board is authorised to represent the company independently. If the company has a management board consisting of 2 (two) or more members of the management board, the company is represented: (i) by the President of the Management Board or the Vice-President acting independently, or (ii) by 2 (two) members of the management board acting jointly, including a member of the management board acting jointly with the President or the Vice-President of the Management Board.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Solvemed Holding Inc. | 1,624 | $21,934.09 | 5.405% |
Others | 28,422 | $383,873.58 | 94.595% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Hugo Jan Chróst (24)  | Sprawowanie kontroli, tj. posiadanie ponad 25% akcji (stock) w solvemed holding inc., która posiada ponad 85% udziałów w kapitale zakładowym solvemed group sp. z o.o. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Advanced Diagnostic Equipmentsp. z o.o. | $43,171.56 | adediabetics.pl | ||
| Micropurasp. z o.o. | $12,556.50 | micropura.eu |
Change history
| Date | Event | |
|---|---|---|
| 2025-07-25 | Share capital change (1,102,300.00 PLN → 1,502,300.00 PLN) | |
| 2025-07-25 | PKD change (Removed: 62.09.Z, 70.22.Z, 72.11.Z, 72.19.Z, 74.90.Z; Added: 62.90.Z, 70.20.Z, 72.10.Z, 74.99.Z) | |
| 2024-11-06 | Share capital change (702,300.00 PLN → 1,102,300.00 PLN) | |
| 2024-06-24 | Share capital change (503,300.00 PLN → 702,300.00 PLN) | |
| 2023-12-18 | Share capital change (93,300.00 PLN → 503,300.00 PLN) |
FAQ
Last updated: 2026-07-15